Cargando…

Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My‐LIFE European Delphi survey

BACKGROUND: Clinical guidelines agree that preventive treatment should be considered in patients with uncontrolled migraine despite acute medications or patients with ≥4 migraine days per month. However, the criteria to define the effectiveness of treatment and the factors that inform the decision t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pozo‐Rosich, Patricia, Gil‐Gouveia, Raquel, Donnet, Anne, Poole, Anne‐Christine, Gendolla, Astrid, Afridi, Shazia, Sanchez‐De la Rosa, Rainel, Terwindt, Gisela M., Tassorelli, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596543/ https://www.ncbi.nlm.nih.gov/pubmed/34173301 http://dx.doi.org/10.1002/ejp.1831

Ejemplares similares

Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process
por: Steiner, Timothy J, et al.
Publicado: (2022)

Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society
por: Diener, Hans Christoph, et al.
Publicado: (2021)

A call for neurologists to take up stroke intervention
por: Padma, Vasantha M., et al.
Publicado: (2016)

Current clinical practice in disabling and chronic migraine in the primary care setting: results from the European My-LIFE anamnesis survey
por: Ryvlin, Philippe, et al.
Publicado: (2021)

Need of guidance in disabling and chronic migraine identification in the primary care setting, results from the european MyLife anamnesis survey
por: Guerrero, Angel L., et al.
Publicado: (2021)

Is migraine with cranial nerve palsy an ophthalmoplegic migraine?
por: Giraud, Pierric, et al.
Publicado: (2007)

Real world preventative drug management of migraine among Spanish neurologists
por: García-Azorin, D., et al.
Publicado: (2019)

Advance in genetics of migraine
por: de Boer, Irene, et al.
Publicado: (2019)

Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study
por: Kollewe, Katja, et al.
Publicado: (2021)

Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
por: Torres-Ferrus, Marta, et al.
Publicado: (2020)

Genetics of migraine aura: an update
por: de Boer, Irene, et al.
Publicado: (2020)

Epidemiology, Demographics, Triptan Contraindications, and Prescription Patterns of Patients with Migraine: A German Claims Database Study
por: Gendolla, Astrid, et al.
Publicado: (2021)

Consensus on the Definition of Advanced Parkinson's Disease: A Neurologists-Based Delphi Study (CEPA Study)
por: Luquin, Maria-Rosario, et al.
Publicado: (2017)

What Do Patients Consider to Be the Most Important Outcomes for Effectiveness Studies on Migraine Treatment? Results of a Delphi Study
por: Smelt, Antonia F. H., et al.
Publicado: (2014)

Functional Neurologic Disorders, disorders to be managed by neurologists, or are neurologists wandering in a dangerous field with inadequate resources?
por: Onofrj, Marco, et al.
Publicado: (2023)

Revised French guidelines for the diagnosis and management of migraine in adults and children
por: Lanteri-Minet, Michel, et al.
Publicado: (2014)

Diagnosis and management of migraine in ten steps
por: Eigenbrodt, Anna K., et al.
Publicado: (2021)

Alienist and Neurologist
Publicado: (1881)

Alumist and Neurologist
Publicado: (1881)

The potential danger of blocking CGRP for treating migraine in CADASIL patients
por: de Boer, Irene, et al.
Publicado: (2020)

Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine
por: Pijpers, Judith A, et al.
Publicado: (2020)

Evaluating the Impact of a Training Program in Shared Decision-Making for Neurologists Treating People with Migraine
por: Porta-Etessam, J., et al.
Publicado: (2023)

Linking migraine frequency with family history of migraine
por: Pelzer, Nadine, et al.
Publicado: (2018)

Alterations in metabolic flux in migraine and the translational relevance
por: Grech, Olivia, et al.
Publicado: (2022)

Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials
por: Reuter, Uwe, et al.
Publicado: (2019)

EHMTI-0270. Experience with onabotulinumtoxin type a in high-frequency episodic migraine
por: Pozo-Rosich, P, et al.
Publicado: (2014)

EHMTI-0283. Predictors of early response to onabotulinumtoxin type a in chronic migraine
por: Mas-Sala, N, et al.
Publicado: (2014)

The Role of Glial Cells in Different Phases of Migraine: Lessons from Preclinical Studies
por: Vila-Pueyo, Marta, et al.
Publicado: (2023)

Triptan efficacy does not predict onabotulinumtoxinA efficacy but improves with onabotulinumtoxinA response in chronic migraine patients
por: Eren, Ozan E., et al.
Publicado: (2020)

Impact of Puberty in Pediatric Migraine: A Pilot Prospective Study
por: Fonseca, Elena, et al.
Publicado: (2020)

Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials
por: Jedynak, Jakub, et al.
Publicado: (2021)

Brain atrophy following hemiplegic migraine attacks
por: Pelzer, Nadine, et al.
Publicado: (2017)

Take my breath away
por: Thomas, Vinai C, et al.
Publicado: (2017)

EHMTI-0048. Epigenetic changes in a rat model of migraine with aura
por: Vila-Pueyo, M, et al.
Publicado: (2014)

Psychiatrists, Neurologists and the Neurosurgeon
por: Cushing, Harvey
Publicado: (1935)

The Training of the Neurologist and the Psychiatrist
Publicado: (1937)

An Eighteenth Century Neurologist
por: Comrie, John D.
Publicado: (1925)

Neurologists' detection and recognition of mental disorder in a tertiary in-patient neurological unit
por: Dawood, Samr, et al.
Publicado: (2018)

Premonitory symptoms in glyceryl trinitrate triggered migraine attacks: a case-control study
por: Onderwater, Gerrit L.J., et al.
Publicado: (2020)

Effect of lockdown during COVID-19 on migraine: A longitudinal cohort study
por: Verhagen, Iris E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cmjq3j01ueuedolj0m21qirj2v